medRxiv PreprintsInternational14 October 2026
A Growing Burden, a Persistent Gap: Cannabinoid Hyperemesis Syndrome Education and Emergency Department Trends in Michigans Legal Cannabis Market
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Since Michigan's legalization of recreational adult-use cannabis in December 2018, health care providers in the city of Kalamazoo, Michigan, have informally observed an increase in cannabinoid hyperemesis syndrome (CHS) presentations, although the extent of this increase has not been formally characterized locally. CHS is frequently underrecognized and misdiagnosed, often resulting in repeated emergency department (ED) visits and substantial diagnostic costs before a diagnosis is reached. Despite this clinical and financial burden, it is unclear whether consumers are adequately inf
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- OSS-DBS v2: Simulation Platform for Biophysical Modelling of Deep Brain Stimulation14 October 2026
- Language eligibility criteria and enrolled racial and ethnic composition in US clinical trials: a cross-sectional study13 October 2026
- Contrasting Patterns of Cortical Volume Change in First-Episode Schizophrenia-Spectrum Psychosis13 October 2026
- Atrial fibrillation begets atrial fibrillation - serum-driven amplification of atrial electrical instability13 October 2026
- Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers13 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.